Modeling and simulation in clinical pharmacology and dose finding.
CPT Pharmacometrics Syst Pharmacol
; 2: e29, 2013 Feb 27.
Article
em En
| MEDLINE
| ID: mdl-23835940
ABSTRACT
The breakout session 2 of the European Medicines Agency/European Federation of Pharmaceutical Industries and Associations Modeling and Simulation (M&S) workshop focused on two topics when and how M&S should be used and would be accepted by the authorities for the dose-regimen selection; and when and how M&S can be applied to register a dosing regimen without the need for a specific study. Each topic was introduced by an industry and regulatory perspective, followed by case examples for illustration (Table 1).CPT Pharmacometrics & Systems Pharmacology (2013) 2, e29; doi10.1038/psp.2013.5; advance online publication 27 February 2013.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
Idioma:
En
Revista:
CPT Pharmacometrics Syst Pharmacol
Ano de publicação:
2013
Tipo de documento:
Article